Ligand Pharmaceuticals Incorporated (LGND) Insider Trading

Total insider buys:
  • $5,339,328.39
Total insider sells:
  • $218,162,557.55
Most recent insider trade:
  • Sept. 23, 2024
Most active insider trader:
  • John L Higgins
Trader NameDateTitleAmountPriceTypeTotal Value
July 31, 2019Director4,004$99.22Buy$397,276.88
July 31, 2019CEO1,850$95.45Buy$176,582.50
July 29, 2019Director250$106.01Buy$26,502.50
June 11, 2019Director250$107.01Buy$26,752.50
May 31, 2019Director1,000$109.51Buy$109,510.00
May 29, 2019Director250$111.01Buy$27,752.50
May 20, 2019Director250$112.01Buy$28,002.50
May 14, 2019CEO2,500$113.50Buy$283,750.00
May 14, 2019Director250$112.51Buy$28,127.50
March 13, 2019CEO2,500$114.29Buy$285,725.00
March 13, 2019Director202$112.51Buy$22,727.02
Oct. 8, 2018Director2,500$253.99Sell$634,975.00
Oct. 1, 2018Director2,500$275.04Sell$687,600.00
Oct. 1, 2018COO12,000$273.88Sell$3,286,560.00
Sept. 17, 2018SVP2,813$250.69Sell$705,190.97
Sept. 4, 2018Insider12,000$255.01Sell$3,060,120.00
Sept. 4, 2018SVP19,417$254.99Sell$4,951,140.83
Sept. 4, 2018Director3,335$254.96Sell$850,291.60
Aug. 30, 2018CEO3,500$258.25Sell$903,875.00
Aug. 29, 2018EVP18,357$256.69Sell$4,712,058.33
Aug. 17, 2018CEO34,500$241.96Sell$8,347,620.00
Aug. 17, 2018Director9,000$239.78Sell$2,158,020.00
July 2, 2018Director2,500$207.48Sell$518,700.00
June 4, 2018Director4,000$194.51Sell$778,040.00
May 15, 2018CEO12,405$179.97Sell$2,232,527.85
May 10, 2018Insider8,881$167.63Sell$1,488,722.03
April 2, 2018Director2,500$160.43Sell$401,075.00
March 12, 2018Director622$180.73Sell$112,414.06
March 9, 2018Director7,500$175.73Sell$1,317,975.00
March 5, 2018Director3,335$160.90Sell$536,601.50
Feb. 27, 2018Director17,170$152.37Sell$2,616,192.90
Feb. 23, 2018COO5,444$152.98Sell$832,823.12
Feb. 23, 2018Director3,417$155.00Sell$529,635.00
Feb. 15, 2018CEO9,000$157.03Sell$1,413,270.00
Jan. 24, 2018CEO22,500$165.00Sell$3,712,500.00
Jan. 19, 2018CEO28,099$153.70Sell$4,318,816.30
Jan. 10, 2018Director2,500$145.00Sell$362,500.00
Dec. 20, 2017Director925$137.25Sell$126,956.25
Nov. 17, 2017VP6,559$142.63Sell$935,510.17
Nov. 16, 2017Director5,000$141.71Sell$708,550.00
Nov. 16, 2017CEO5,269$142.53Sell$750,990.57
Sept. 5, 2017CEO5,000$130.00Sell$650,000.00
Aug. 23, 2017Director2,000$127.99Sell$255,980.00
Aug. 9, 2017Insider6,100$127.51Sell$777,811.00
Aug. 9, 2017VP18,625$126.96Sell$2,364,630.00
Aug. 8, 2017CEO5,483$125.00Sell$685,375.00
June 21, 2017CEO4,666$120.00Sell$559,920.00
June 9, 2017CEO12,000$114.87Sell$1,378,440.00
May 12, 2017Insider5,621$112.20Sell$630,676.20
May 12, 2017Director37,247$110.76Sell$4,125,477.72
  • Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.

  • The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Charles S Berkman, Matthew E Korenberg, Todd C Davis, Octavio Espinoza, Andrew Reardon, Bvf Partners L P/Il, Stephen L Sabba, John L Lamattina, David M Knott, Melanie J Herman, Bvf Partners P/Il, Sunil Patel, Matthew Foehr, David Knott, Nishan M Desilva, Charles Berkman, John Sharp, John Higgins, Todd Davis, John Lamattina, Melanie J. Herman, and John W. Kozarich

  • The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.

  • Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.

  • Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.

  • The most recent insider trade for Ligand Pharmaceuticals Incorporated was on Sept. 23, 2024.

  • The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Bvf Partners L P/Il with a total value of $898,794.00 on Dec. 6, 2012.

  • The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.